Found: 28
Select item for more details and to access through your institution.
Significance of the autoantibody assay in predicting the development of immune‐related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2024, v. 54, n. 2, p. 162, doi. 10.1111/hepr.13969
- By:
- Publication type:
- Article
Significance of serum IP‐10/CXCL10 measurement in predicting post‐direct acting antiviral treatment liver function in patients with HCV‐decompensated liver cirrhosis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 4, p. 280, doi. 10.1111/hepr.13861
- By:
- Publication type:
- Article
Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography.
- Published in:
- Hepatology Research, 2023, v. 53, n. 3, p. 208, doi. 10.1111/hepr.13858
- By:
- Publication type:
- Article
Deep sequencing analysis of serum hepatitis B virus‐RNA during nucleot(s)ide analogue therapy.
- Published in:
- Hepatology Research, 2021, v. 51, n. 1, p. 39, doi. 10.1111/hepr.13574
- By:
- Publication type:
- Article
Cancer‐related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1071, doi. 10.1111/hepr.13529
- By:
- Publication type:
- Article
Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0209509
- By:
- Publication type:
- Article
The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment.
- Published in:
- Internal Medicine, 2022, v. 61, n. 18, p. 2721, doi. 10.2169/internalmedicine.8456-21
- By:
- Publication type:
- Article
Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma‐like area and metachronous hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2019, v. 49, n. 12, p. 1466, doi. 10.1111/hepr.13403
- By:
- Publication type:
- Article
Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 51, doi. 10.1111/hepr.13277
- By:
- Publication type:
- Article
Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients.
- Published in:
- Hepatology Research, 2014, v. 44, n. 7, p. 720, doi. 10.1111/hepr.12179
- By:
- Publication type:
- Article
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 655, doi. 10.1159/000531689
- By:
- Publication type:
- Article
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 609, doi. 10.1159/000531111
- By:
- Publication type:
- Article
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2023, v. 101, n. 3, p. 173, doi. 10.1159/000527752
- By:
- Publication type:
- Article
Reduced Organic Anion Transporter Expression Is a Risk Factor for Hepatocellular Carcinoma in Chronic Hepatitis C Patients: A Propensity Score Matching Study.
- Published in:
- Oncology, 2014, v. 86, n. 1, p. 53, doi. 10.1159/000356643
- By:
- Publication type:
- Article
Specific Protein Delivery to Target Cells by Antibody-displaying Bionanocapsules.
- Published in:
- Journal of Biochemistry, 2008, v. 144, n. 6, p. 701, doi. 10.1093/jb/mvn131
- By:
- Publication type:
- Article
Spontaneous portosystemic shunt diameter predicts liver function after balloon‐occluded retrograde transvenous obliteration.
- Published in:
- JGH Open, 2022, v. 6, n. 2, p. 139, doi. 10.1002/jgh3.12712
- By:
- Publication type:
- Article
Role of magnifying endoscopy with narrow‐band imaging in the diagnosis of noninvasive gastric neoplasia.
- Published in:
- JGH Open, 2021, v. 5, n. 4, p. 446, doi. 10.1002/jgh3.12513
- By:
- Publication type:
- Article
Genetic alterations related to endoscopic treatment of colorectal tumors.
- Published in:
- JGH Open, 2020, v. 4, n. 1, p. 75, doi. 10.1002/jgh3.12220
- By:
- Publication type:
- Article
Effect of a combination of pemafibrate and a mild low‐carbohydrate diet on obese and non‐obese patients with metabolic‐associated fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 6, p. 921, doi. 10.1111/jgh.16154
- By:
- Publication type:
- Article
Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 2, p. 229, doi. 10.1002/cncr.28384
- By:
- Publication type:
- Article
Usefulness of Body Position Change during Local Ablation Therapies for the High-Risk Location Hepatocellular Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1036, doi. 10.3390/cancers16051036
- By:
- Publication type:
- Article
HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0212559
- By:
- Publication type:
- Article
Semiannual Imaging Surveillance Is Associated with Better Survival in Patients with Non-B, Non-C Hepatocellular Carcinoma.
- Published in:
- Mediators of Inflammation, 2015, v. 2015, p. 1, doi. 10.1155/2015/687484
- By:
- Publication type:
- Article
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
- Published in:
- Journal of Gastroenterology, 2018, v. 53, n. 6, p. 780, doi. 10.1007/s00535-017-1405-3
- By:
- Publication type:
- Article
Association between alanine aminotransferase elevation and UGT1A1*6 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 11, p. 1495, doi. 10.1007/s00535-013-0914-y
- By:
- Publication type:
- Article
Genetic variation near interleukin 28B and the risk of hepatocellular carcinoma in patients with chronic hepatitis C.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 7, p. 1152, doi. 10.1007/s00535-013-0858-2
- By:
- Publication type:
- Article
Usefulness of Circulating CYFRA21-1 in Patients as a Biomarker in Patients Taking Sorafenib or Lenvatinib for Unresectable Hepatocellular Carcinoma.
- Published in:
- Reports (MDPI AG), 2021, v. 4, n. 3, p. 1, doi. 10.3390/reports4030025
- By:
- Publication type:
- Article